CD274 and thymic carcinoma: Bintrafusp alfa, a bifunctional protein that functions as a TGF-β ‘trap’ and a PD-L1 inhibitor, is under evaluation in patients with previously treated advanced thymoma and thymic carcinoma (NCT04417660; Figure 2) [63].